H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

CEO

Mr. Charl van Zyl

Employees

5707

Country

ISIN

DK0061804697

Listings

0 Comments

Share your thoughts

FAQ

What is H. Lundbeck AS stock price today?▼

The current price of HLUBF is $4.82 USD — it has increased by +0% in the past 24 hours. Watch H. Lundbeck AS stock price performance more closely on the chart.

What is H. Lundbeck AS stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange H. Lundbeck AS stocks are traded under the ticker HLUBF.

Is H. Lundbeck AS stock price growing?▼

HLUBF stock has risen by +0% compared to the previous week, the month change is a -9.4% fall, over the last year H. Lundbeck AS has showed a -11.23% decrease.

What is H. Lundbeck AS revenue for the last year?▼

H. Lundbeck AS revenue for the last year amounts to 7.66B USD.

What is H. Lundbeck AS net income for the last year?▼

HLUBF net income for the last year is 988.97M USD.

Does H. Lundbeck AS pay dividends?▼

Yes, HLUBF dividends are paid annual. The last dividend per share was 0.18 USD. As of today, Dividend Yield (FWD)% is 3.69%.

How many employees does H. Lundbeck AS have?▼

As of April 06, 2026, the company has 5,707 employees.

In which sector is H. Lundbeck AS located?▼

H. Lundbeck AS operates in the Health Care sector.

When did H. Lundbeck AS complete a stock split?▼

H. Lundbeck AS has not had any recent stock splits.

Where is H. Lundbeck AS headquartered?▼

H. Lundbeck AS is headquartered in Valby, DK.